Latest S-1 registration statements

OS Therapies is registering for resale up to 10.8 million common shares, representing securities issuable from a recent private placement involving convertible preferred stock and warrants.

QT Imaging Holdings files an amendment to its registration statement, covering the potential resale of 8.8 million shares of common stock by selling securityholders.

TV Channels Network Inc., a Nevada-based music and entertainment technology company, has filed a registration statement for an initial public offering (IPO) to raise capital for operations, software development, and content acquisition.

Acurx Pharmaceuticals is registering for resale 2.6 million shares of common stock previously issued or issuable upon exercise of warrants to certain investors.

Neuralbase AI Ltd. is seeking to raise $400,000 through a direct public offering of 40 million common shares to further develop its AI-driven document processing platform, Multidoc.ai.

Thoughtful Media Group has filed an amendment to its S-1 registration statement, detailing its upcoming initial public offering and a concurrent resale offering.

Aspira Womens Health is launching a public offering of up to 50 million units and 50 million pre-funded units to raise capital for working capital and general corporate purposes.

Fifth Era Acquisition Corp I, a blank check company, is set to launch a $200 million IPO to pursue a merger, acquisition, or reorganization with a technology-focused business.

Odysight.ai Inc. files an amendment to its S-1 registration statement, detailing its proposed public offering and application to list on the Nasdaq Capital Market.

Rain Enhancement Technologies Holdco, Inc. details the resignation of its Co-CEO, Christopher Riley, and files an S-1 registration statement for the issuance and resale of shares.

Faraday Future is registering over 25 million shares of Class A Common Stock for resale, including shares tied to convertible notes and a settlement with a former vendor, as the company navigates its financial challenges.

T Stamp Inc. has filed an amendment to its S-1 registration statement to allow for the resale of up to 2,096,842 shares of Class A Common Stock by a selling stockholder.

NeOnc Technologies has engaged RBW Capital Partners for financial advisory services related to its direct listing on Nasdaq and a private placement of common stock.

Maze Therapeutics has filed a registration statement to increase the number of shares offered in its public offering by 1,092,500, including an underwriter option.

Celularity Inc. announces a public offering of up to 6,521,739 shares of Class A common stock and pre-funded warrants to raise capital for working capital and general corporate purposes.

Sonnet BioTherapeutics is seeking to register up to 2,000,000 shares of common stock for potential sale by Chardan Capital Markets, aiming to raise up to $25 million through a committed equity facility.

Sonnet BioTherapeutics is registering for resale 127,500 shares of common stock and 2,303,825 shares issuable upon exercise of warrants, following recent private placements.

Nexalin Technology is filing an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Enveric Biosciences has filed an amendment to its S-1 registration statement, primarily to include updated exhibits related to its financial and legal agreements.

Hashdex Nasdaq Crypto Index US ETF establishes a cash custody agreement with U.S. Bank National Association for safekeeping of fund assets.

Klotho Neurosciences is registering for resale up to 43.7 million shares of common stock, including shares issuable upon conversion of notes and exercise of warrants, by existing shareholders.

High Wire Networks, Inc. is seeking to raise capital through a public offering of 750,000 shares and register the resale of 583,296 shares by existing stockholders.

Enveric Biosciences is seeking to raise capital through an offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants.

Maze Therapeutics, a clinical-stage biopharmaceutical company, has filed for an initial public offering to advance its pipeline of precision medicines for renal, cardiovascular, and metabolic diseases.

Solidion Technology, Inc. has filed an amendment to its Form S-1 registration statement, potentially allowing existing securityholders to resell up to 293,457,926 shares of common stock.

K&F Growth Acquisition Corp. II has formalized its share rights agreement with Continental Stock Transfer & Trust Company in preparation for its initial public offering.

Scienture Holdings has filed an amendment to its S-1 registration statement to allow for the resale of up to 4.3 million shares of common stock by certain selling stockholders.

Beta Bionics files a registration statement to increase the number of shares offered in its public offering by 2,300,000, including an underwriter option, following the effectiveness of its initial S-1 registration.

Artius II Acquisition Inc., a blank check company, is set to launch a $200 million IPO targeting technology-enabled businesses.

Permex Petroleum intends to register for resale up to 4,699,394 common shares issuable upon conversion of debentures and exercise of purchase warrants.